RCUS · Company research
Arcus Biosciences, Inc. (RCUS): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 24.28 | $3,153,761,000 | 3003761000.00 | 34.3802816901408451 | — | — | 76.9210000000000000 | 6.7968987068965517 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.